Acadian Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-671,581
| Closed | -$3.34M | – | 2315 |
|
|
2021
Q1 | $3.34M | Buy |
671,581
+217,317
| +48% | +$1.08M | 0.01% | 580 |
|
|
2020
Q4 | $1.96M | Buy |
454,264
+169,575
| +60% | +$731K | 0.01% | 763 |
|
|
2020
Q3 | $1.22M | Buy |
284,689
+264,952
| +1,342% | +$1.14M | 0.01% | 832 |
|
|
2020
Q2 | $89K | Buy |
+19,737
| New | +$89K | ﹤0.01% | 1749 |
|
|
2017
Q2 | – | Sell |
-29,759
| Closed | -$210K | – | 1667 |
|
|
2017
Q1 | $210K | Buy |
29,759
+10,134
| +52% | +$71.5K | ﹤0.01% | 1035 |
|
|
2016
Q4 | $83K | Buy |
19,625
+18,173
| +1,252% | +$76.9K | ﹤0.01% | 1118 |
|
|
2016
Q3 | $7K | Hold |
1,452
| – | – | ﹤0.01% | 1282 |
|
|
2016
Q2 | $5K | Buy |
1,452
+114
| +9% | +$393 | ﹤0.01% | 1309 |
|
|
2016
Q1 | $5K | Sell |
1,338
-2,474
| -65% | -$9.25K | ﹤0.01% | 1281 |
|
|
2015
Q4 | $13K | Buy |
+3,812
| New | +$13K | ﹤0.01% | 1199 |
|